about
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depressionMapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain.N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons.Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress.Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria.The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis.Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice.Molluscs as models for translational medicine.Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain.Acute and chronic changes in K(+)-induced depolarization alter NMDA and nNOS gene expression in cultured cerebellar granule cells.Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain.Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats.Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats.Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats.Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function.Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice.Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor.Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain.Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts.Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus.Circulating phagocytes: the ancient and conserved interface between immune and neuroendocrine function.Molecular changes associated with escitalopram response in a stress-based model of depression.Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression.Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype.Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate).Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine.Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection.Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs.Epigenetic modification in neurons of the mollusc Pomacea canaliculata after immune challenge.Regulation of NMDA receptor subunit mRNA expression in the rat brain during postnatal development.Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells.Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2P.1.03 Molecular effects of subchronic and chronic treatment with escitalopram in the rat central nervous systemS.15.03 Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressionAcetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depressionP.2.d.012 Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depressionEffects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depressionThe Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to TreatmentPsychosocial assessment of families caring for a child with acute lymphoblastic leukemia, epilepsy or asthma: Psychosocial risk as network of interacting symptoms
P50
Q28217850-1B151E57-E91F-4BF2-A255-C539761E4FD8Q37350317-2E565F76-D2B7-4722-8750-D62CC030DC27Q39165434-DA3E9036-1E24-42D0-A70C-8219F9CACA38Q39295049-043043BF-7518-4B79-ACE2-F6014DA1D21DQ39705798-8F9F9D1E-3DC8-408E-B1AE-05770CEE21A2Q39793088-802E3C33-10D6-4E89-98A5-A12A80B80672Q40282612-E5E30CA9-AFB5-4678-A568-B8FE7D2716A5Q40524322-AA8FA386-B084-472B-B520-74FD6257E3A4Q41701694-96FC24D7-9C90-4F4A-B5BF-8464BBD49484Q42524392-BCEABA33-F589-4E24-BB21-73C03DC57104Q42595545-1130C3D8-68FC-423F-8401-F0573E0126B0Q42989395-076826E6-2D69-4AC4-8BD8-1461D6F8AAC1Q43285150-818C3CEE-E5DB-4577-BB1A-1DAB67578881Q43722702-47636ADE-CF6F-44B4-B312-9B4883B69FA3Q43942965-AB5FBE0D-7EC9-4970-84B2-D05629283B0DQ44085479-556F841D-6262-48A8-8CBD-760CF385C8E0Q44532054-91B83F95-03EF-43A5-9F27-D31060FEB962Q45157405-2F70811C-DD22-4609-B1A4-087D95618021Q46367558-83AEABAC-4F91-42B9-8B67-94395517671DQ46383816-B459BAA9-B4A5-42BA-85F9-A4333ABE0A86Q46494634-BAE5742A-32F1-46E6-9C8A-B71921C46D40Q47364499-DE38A9EC-DE44-4031-B8B4-0D019BEA3765Q47628442-2298A8C0-33E2-489A-AED9-DEBD44E46713Q47753809-34983866-9942-4ACB-9317-86C85FBE7731Q48133401-0C83827D-2B4B-4C6B-9F8D-9E54266F257FQ48146556-72BF7875-335E-4254-8051-59ED5C3EFCF7Q48148651-EAFE398F-1869-4D70-9F73-640787153E57Q48160134-547E3E35-1F3E-454D-9E53-69E7D152E28DQ48581049-DDECFF20-BCBA-4CDC-90EB-26D7CB92EA15Q49023866-C5E4442E-7CEB-4141-A873-6C1FB0BD5FEEQ52214910-464F61E7-AC7A-4ED0-8C87-D1C5E259BF20Q54372515-48C5D3F5-252E-40D8-ABE6-A6BC1B30C6B7Q56965966-1D598DC0-C177-4A5F-A7ED-9D671B7C6944Q59264480-4ECA6A30-DB73-437B-971E-23F29517750AQ59264486-B636C523-4EBE-4496-9753-68078E308B8BQ59264490-F7C0F74B-DB93-4D89-B66C-75DD7E9C76FAQ59264496-DE989296-474F-4393-9924-366B2AFFF87DQ59264498-44BF912D-69EF-4ED5-AFFE-C27D00C52B0EQ90264202-D58A75F3-80C9-483F-8730-AC47B217C8FAQ90592352-172548D0-9FE9-468D-9013-5650716005E4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabio Tascedda
@ast
Fabio Tascedda
@en
Fabio Tascedda
@es
Fabio Tascedda
@nl
Fabio Tascedda
@sl
type
label
Fabio Tascedda
@ast
Fabio Tascedda
@en
Fabio Tascedda
@es
Fabio Tascedda
@nl
Fabio Tascedda
@sl
prefLabel
Fabio Tascedda
@ast
Fabio Tascedda
@en
Fabio Tascedda
@es
Fabio Tascedda
@nl
Fabio Tascedda
@sl
P1053
C-7133-2015
P106
P1153
8062263200
P21
P2798
P31
P3829
P496
0000-0002-0958-7333